← All organizations
Highest phase reached
Phase 1
First clinical trial
Sep 16, 2024Last known activity
Sep 16, 2024
Timeline
2010s
- Jan 1, 2019
KaliVir Immunotherapeutics— Founded
Drugs by trial phase (2 distinct, 1 trials)
Phase 1 (2 own, 0 via acquisition)
Recent trials (1)
- NCT06444815Lead sponsorPhase 1Sep 16, 2024
Details
- Founded
- London, GB Jan 1, 2019
- Last known activity
- Sep 16, 2024